GS-4528 clinical trials

Study of GS-4528 in Adults With Solid Tumors

This study is testing a new drug, GS-4528, on its own or with another drug, Zimberelimab, for adults with solid cancers. Researchers want to find out if it's safe, what dose works best, and if people can tolerate it.